A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

NCT03170388 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

741

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: IDP-126 Gel
DRUG: IDP-126 Component A
DRUG: IDP-126 Component B
DRUG: IDP-126 Component C
DRUG: IDP-126 Vehicle Gel

Sponsor

Bausch Health Americas, Inc.